Registration for a live webinar on 'Innovations in antibiotic discovery: combating resistant infections' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Introduction to the World of Hormones
-
1. Introduction to hormones
- Prof. Helen Henry
- The Reproductive Hormones
-
2. Endocrinology of parturition
- Dr. Errol Norwitz
-
3. Menopausal hormone therapy
- Prof. Hugh Taylor
- Hormones in Calcium and Phosphorus Homeostasis
-
5. Vitamin D endocrine system: basics
- Prof. Anthony Norman
-
6. Vitamin D endocrine system: mechanisms to produce biological responses
- Prof. Anthony Norman
-
7. Parathyroid hormone and parathyroid hormone-related protein
- Prof. Robert Nissenson
- Hormones and the Vasculature
-
9. Vascular cell signaling by membrane estrogen receptors
- Prof. Jeffrey Bender
- Hormones and Energy Metabolism
-
10. Pathogenesis of the metabolic syndrome
- Prof. Richard Bergman
- Hormones and Growth
-
11. The growth hormone/insulin-like growth factor-1 axis in health and disease
- Prof. Derek LeRoith
- Frontiers in Hormone Research
-
12. Prevention of type 1 diabetes
- Prof. Chantal Mathieu
-
13. Actions of steroid hormones in the brain
- Prof. Bruce McEwen
-
14. Vitamin D and prostate cancer
- Prof. David Feldman
- Archived Lectures *These may not cover the latest advances in the field
-
15. G-protein coupled receptors: hormone membrane receptors
- Prof. Stuart Sealfon
-
16. Nuclear receptors: transcriptional functions
- Prof. Nancy Weigel
- Dr. Neil McKenna
-
17. Steroid hormones and their receptors in breast cancer
- Prof. JoEllen Welsh
-
18. Nuclear receptor superfamily: structural insights into function
- Prof. Dino Moras
-
19. Receptor tyrosine kinases - function, families and evolution
- Prof. Tony Hunter
-
20. Can we prevent type I diabetes?
- Prof. Chantal Mathieu
-
21. Vitamin D endocrine system: VDR binding, nutrition and drugs development
- Prof. Anthony Norman
Printable Handouts
Navigable Slide Index
- Introduction
- Number of postmenopausal women in the US
- Menopause health risks
- Outline
- Why women initiate or continue ERT/HRT
- Menopause: HRT benefits
- Controversies in management
- Women's health initiative (WHI) study
- WHI E+P: background
- WHI E-alone: background
- WHI E+P: benefits and risks
- WHI estrogen alone
- WHI - drawbacks
- Disease latency
- WHI E+P: hip fracture
- Heart disease
- Factors that influence heart disease
- Effect of estrogen on risk for CHD
- Coronary artery atherosclerosis
- HRT trial: CHD events
- WHI E+P: risk of CHD
- Life history of an atheroma
- Importance of timing of intervention in primates
- WHI: CHD and HT
- Coronary events by age at baseline in WHI
- E-alone: cardiovascular outcomes ages 50-59
- CEE and coronary artery calcium at age 50-59
- KEEPS trial
- CHD events in the WHI E-only arm
- Breast cancer
- Review of studies published from 1975-2000
- WHI results: breast cancer
- WHI - ET arm: breast cancer
- Meaning of risk of breast cancer detection
- Time course for breast cancer development
- WHI E+P: effect on risk of in situ breast cancer
- Cumulative hazards for breast cancer
- WHI results: mortality
- Diseases with a long latency period
- Low dose is recommended
- Women's HOPE study
- Women's HOPE study: total hip BMD
- Conclusions
Topics Covered
- Menopause health risks
- Hormone therapy in perspective
- Reasons for continuing or initiating ERT/HRT
- HRT benefits
- Women's health initiative (WHI)
- Heart disease
- Effect of Estrogen on risk of CHD
- Breast cancer
- Increased risk of breast cancer detection is not the same as breast cancer mortality or causality
- The WHI did not consider disease latency
- Low doses are recommended
- Women's HOPE study
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Taylor, H. (2007, December 1). Menopausal hormone therapy [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 24, 2025, from https://doi.org/10.69645/VHUZ7606.Export Citation (RIS)
Publication History
- Published on December 1, 2007
Financial Disclosures
- Prof. Hugh Taylor has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Menopausal hormone therapy
Published on December 1, 2007
54 min